CA Rudramurthy BV of Vachana Investments told CNBC-TV18, "Sun Pharmaceutical Industries is a clear outperformer, Rs 840 levels is a very strong support for intermediary as well as long-term investors to buy and definitely suggesting a buy for short-term traders on Sun Pharmaceuticals. While built up is seen on the positive side and one can see levels of Rs 885-900 for traders keeping a strict stoploss of Rs 855."The share touched its 52-week high Rs 1,200.70 and 52-week low Rs 706.40 on 07 April, 2015 and 24 November, 2015, respectively.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
